Related by context. All words. (Click for frequent words.) 64 non squamous 60 squamous cell lung cancer 60 medically inoperable 60 squamous non 59 cytotoxic therapies 58 nonsmall cell lung cancer 58 urothelial cancer 58 Bone marrow transplantation 58 CyPath ® 58 pancreatic adenocarcinoma 58 prophylactic cranial irradiation 58 Radiofrequency ablation 58 malignant pleural mesothelioma 58 miRview ™ squamous 57 radionuclide therapy 57 dacarbazine chemotherapy 57 NSCLC tumors 57 anti angiogenic agents 57 radioimmunotherapy RIT 57 radiation therapy SBRT 57 GIST tumors 57 cisplatin resistant 57 stereotactic radiotherapy 57 prognostically 57 transrectal ultrasound guided 56 amphotericin 56 concurrent chemoradiation 56 metabonomics 56 ALK inhibitors 56 BRAF inhibitors 56 cediranib 56 diagnose coronary artery 56 preoperative staging 56 antiangiogenic therapy 56 Medullary thyroid cancer 56 HER2 positive cancers 56 percutaneous biopsy 56 prostate carcinoma 56 seminoma 56 treating uterine fibroids 56 immunosuppressive regimens 56 genomic profiling 56 differentiated thyroid 56 serologic tests 56 stage IIIB IV 56 flavopiridol 56 noninvasive imaging 56 castrate resistant 56 intraperitoneal therapy 55 epithelial tumors 55 Gleevec resistant 55 kidney urologic 55 hypofractionated 55 peritoneal carcinomatosis 55 SIR Spheres 55 metastatic neuroendocrine tumors 55 intra arterial chemotherapy 55 metastatic lymph nodes 55 colon capsule endoscopy 55 antiangiogenic agent 55 KRAS mutant 55 KRAS mutation 55 diagnosing coronary artery 55 Surgical resection 55 antibiotic regimens 55 tumor excision 55 fumagillin nanoparticles 55 gynecological malignancies 55 Velculescu 55 operable breast cancer 55 pilocytic astrocytomas 55 transarterial chemoembolization 55 murine models 55 benign neoplasms 55 adeno associated viruses 55 treat brain aneurysms 55 radiolabeled TM# 55 diagnostic biomarker 55 prostate carcinomas 55 renal carcinoma 55 intracavitary 55 Tr DNA 54 hormone receptor status 54 adoptive immunotherapy 54 androgen ablation 54 myeloablative 54 GBMs 54 individualize therapy 54 efficacy evaluable 54 renal tumors 54 diagnostic modality 54 mutated K ras 54 CyPath ® assay 54 lung cancer NSCLC 54 Glioblastoma Multiforme GBM 54 molecularly defined 54 dosimetric 54 balloon brachytherapy 54 lymphomas leukemias 54 sentinel lymph node biopsy 54 curative therapy 54 endocrine therapies 54 serous ovarian cancer 54 stratifying patients 54 gefitinib Iressa 54 urologic surgeons 54 diagnose Alzheimer disease 54 tumor biopsies 54 virotherapy 54 recurrent glioblastoma multiforme 54 treating neuropathic pain 54 pharmacologic stress 54 intraductal 54 Hurthle cell 54 cellulase enzymes 54 conformal radiotherapy 54 colorectal cancer liver metastases 54 allogeneic HSCT 54 KRAS oncogene 54 TransMID TM 54 PET CT scanning 54 chemoresistant 54 malignant growths 54 trastuzumab DM1 54 #T# L1 54 lymphatic mapping 54 produces radioisotopes 54 cervical lymph node 54 metaplasia 53 Basal cell 53 perfusion CT 53 bioluminescence imaging 53 vitro maturation IVM 53 spontaneously regress 53 Litx 53 siRNA compounds 53 HNSCC 53 carcinoid 53 histologic subtype 53 guaiac 53 mucinous 53 surgical oncologists 53 bioassay 53 microRNA biomarkers 53 SPECT CT imaging 53 radiofrequency ablation RFA 53 genomic alterations 53 treat chronic sinusitis 53 leukemia multiple myeloma 53 EGFR mutation positive 53 MiCK assay 53 electrochemical detection 53 KRAS mutations occur 53 chemoprevention trials 53 OvaRex MAb 53 Adjuvant chemotherapy 53 resectable 53 completely resected 53 recurrent metastatic 53 Stereotactic radiosurgery 53 FDG PET imaging 53 adjuvant therapies 53 miRNA biomarkers 53 hematopoietic cancers 53 oncologic outcomes 53 radiotracers 53 Balloon sinuplasty 53 serological testing 53 nonviral 53 endoscopic ultrasound EUS 53 bioassays 53 tolevamer 53 stage IIIA 53 iPSC 53 inactivated influenza vaccines 53 detecting colorectal cancer 53 CBLC# 53 Temsirolimus 53 oncological outcomes 53 needle aspiration 53 multiplexed assays 53 BREVAGen ™ 53 Neoadjuvant chemotherapy 53 spontaneous regression 53 bortezomib Velcade 53 esophageal gastric 53 cytoreduction 53 S. maltophilia 53 seminomas 53 BACcel 53 histological subtype 53 treating cancerous tumors 53 refractory colorectal cancer 52 PET tracers 52 metastatic ovarian cancer 52 nodal metastasis 52 nonpharmacologic 52 genomic biomarker 52 Lung transplantation 52 metastatic gastric 52 intra abdominal infections 52 EGFR tyrosine kinase inhibitors 52 Li Fraumeni 52 tumor subtype 52 gynaecologic 52 thyroid carcinoma 52 PTK# 52 pituitary adenomas 52 cell culturing 52 serological tests 52 osteosarcomas 52 lymphoproliferative disorders 52 stem cell transplantations 52 TRUS biopsy 52 indolent lymphomas 52 tumor histology 52 intensity modulated radiotherapy IMRT 52 tumor subtypes 52 HLA DQ2 52 NCCN guidelines 52 malignant ascites 52 taxane therapy 52 invasive lobular carcinoma 52 bronchogenic carcinoma 52 HIFU therapy 52 immunosuppressive regimen 52 treat enlarged prostate 52 ALI ARDS 52 lung carcinomas 52 mTOR inhibitors 52 nomograms 52 NovoTTF 52 biliary stones 52 histologies 52 GISTs 52 malignant lymphomas 52 adenomatous 52 autologous transplants 52 localized prostate 52 bronchoalveolar lavage 52 monoclonal antibody therapies 52 PROLARIS 52 antiplatelet therapies 52 null responder 52 differential gene expression 52 Alequel 52 ablative therapy 52 Dr. Rafii 52 molecular biomarkers 52 relapsed ALL 52 nucleic acids proteins 52 HepDirect prodrug 52 biomarker assay 52 therapeutic radiopharmaceuticals 52 DCVax ® Brain 52 delipidation 52 EBUS 52 molecularly targeted therapies 52 Squamous 52 biomarker identification 52 protein microarrays 52 conventional chemotherapies 52 humanized mouse 52 infiltrative 52 multimodality therapy 52 percutaneous cryoablation 52 Zybrestat 52 Febit 52 druggable targets 52 focal ablation 52 Mendelian randomization 52 foam sclerotherapy 52 prostate cancer metastases 52 chemo immunotherapy 52 hypermethylated 52 transthoracic 52 metastatic breast 52 decortication 52 multivessel coronary artery 52 core needle biopsy 52 Platinol ® cisplatin 52 therapeutic regimens 52 colorectal lung 52 pharmacogenetic testing 52 pretransplant 52 curative resection 51 sputum induction 51 chronotherapy 51 antiangiogenic agents 51 EECP ® therapy 51 FISH fluorescence 51 Radio Frequency Ablation 51 Chronic lymphocytic leukemia 51 vivo molecular imaging 51 Lilly Alimta 51 EasyCD4 51 NADiA 51 KRAS status 51 irinotecan chemotherapy 51 doxorubicin HCl 51 histopathologic findings 51 Panzem 51 hormonally responsive 51 surgical debulking 51 prognostic indicators 51 humanised monoclonal antibody 51 molecular assays 51 lymphoid tumors 51 nonmetastatic 51 prognostic biomarker 51 hoFH patients 51 gastrointestinal stromal tumors 51 endobronchial 51 OHR/AVR# 51 neoadjuvant therapy 51 p# biomarker 51 metastatic liver 51 OnDose TM 51 localized renal 51 Roche Xeloda 51 genotypic resistance 51 treat arrhythmias 51 histopathologic examination 51 frameless radiosurgery 51 NSABP C 51 locoregional recurrence 51 chemotherapeutic regimens 51 Oncotype 51 immunohistochemical analysis 51 Glioblastoma multiforme 51 putative biomarkers 51 hormone refractory 51 metabolomic profiling 51 adjunctively 51 Malignant glioma 51 candidemia 51 sarcomatoid 51 magnetic resonance spectroscopy MRS 51 monogenic 51 Chronic myeloid leukemia 51 administered systemically 51 relapsing remitting MS RRMS 51 bioinformatic analyzes 51 hESC derived cardiomyocytes 51 survivin expression 51 pancreatic islet cell 51 underwent resection 51 immunochemical 51 PSMA ADC 51 laparoscopic radical nephrectomy 51 haplotyping 51 aneuploidy screening 51 embryonic stem cells ESCs 51 electrophysiologic 51 fully sequenced genomes 51 invasive diagnostic 51 MMP inhibitors 51 gene expression microarrays 51 bullous 51 CPVT 51 HER2 amplified 51 bovine thrombin 51 inoperable tumors 51 Chlamydia psittaci 51 cyclophilin inhibitors 51 MAGE A3 ASCI 51 radiochemotherapy 51 biophysical techniques 51 haematologic 51 radiographic outcomes 51 liver metastasis 51 radiologic imaging 51 renal cortical 51 pulmonary metastases 51 hepatocellular carcinomas 51 adjuvant cisplatin 51 mutant KRAS 51 parthenolide 51 nanosurgery 51 patients undergoing chemotherapy 51 Metastatic colorectal cancer 51 transplantation HCT 51 SBRT 51 LBH# 51 Radical prostatectomy 51 TransMID 51 haematological cancers 51 Cystoscopy 51 5 fluorouracil leucovorin 51 Dr. Cliby 51 remnant ablation 51 demonstrated antitumor activity 51 phenotypic expression 51 HIPEC 51 Surgical excision 51 Sudhir Agrawal D.Phil 51 alkylating agent 51 acetabular fractures 51 invasive biopsy 51 pretreatment serum 51 biliary tract cancer 51 pT2 51 transarterial 51 Hepatocellular Carcinoma HCC 51 percutaneous drainage 51 ANCA associated 51 lung adenocarcinomas 51 molecular abnormalities 51 transrectal ultrasound 51 molecular profiling 51 primary hyperparathyroidism 51 fibrocystic disease 51 invasive carcinoma 51 HepaMate 51 BEXXAR Therapeutic Regimen 51 thyroid nodules 51 CTEPH 50 Histologically 50 renal biopsy 50 metastatic uveal melanoma 50 Balloon angioplasty 50 pig islets 50 dosimetrists 50 synthetic siRNAs 50 endoscopic retrograde 50 precancerous spots 50 excisional 50 gastric cardia 50 radiolabeling 50 immunosuppression therapy 50 symptomatic paroxysmal AF 50 vitro experiments 50 Flexible sigmoidoscopy 50 neoplastic cells 50 hyperplastic polyps 50 somatic mutations 50 PCA3 assay 50 catheter angiography 50 Mohs micrographic surgery 50 lymph node biopsies 50 microwell plate 50 Onconase 50 PrevOnco 50 salivary diagnostics 50 radical nephrectomy 50 enzyme immunoassay EIA 50 carcinoids 50 immunocompetent 50 pancreatic carcinoma 50 laparoscopic nephrectomy 50 pulmonary metastasis 50 ultrasonographic examination 50 novel immunotherapeutic 50 cryosurgery freezing 50 noninvasive diagnostic 50 anti angiogenic drugs 50 lung nodules 50 unresectable tumors 50 combinatorial libraries 50 Illumina genotyping 50 Affibody ® molecules 50 antihormonal 50 eflornithine 50 Colon polyps 50 anaplastic 50 synthetic lethality 50 microdissection 50 prostate cancer CaP 50 GnRH analogue 50 Aplidin 50 pheochromocytoma 50 Mammosite 50 thoracoscopic lobectomy 50 radiotherapy SBRT 50 Endoscopic ultrasound 50 clinically localized prostate 50 nested PCR 50 Prognostic factors 50 cordycepin 50 detecting precancerous 50 pancreatic neuroendocrine tumors 50 GeneSearch 50 non squamous NSCLC 50 gauge vitrectomy 50 GnRH agonists 50 antitumor effect 50 malignant nodules 50 fibroadenomas 50 MyVax 50 surgical revascularization 50 Lymph node 50 autologous transplant 50 Trofex 50 detect precancerous 50 multicenter Phase II 50 diagnosing ADHD 50 Photodynamic therapy PDT 50 chemotherapeutic regimen 50 meningiomas 50 glycopeptides 50 metastatic basal cell 50 HER2 positive breast 50 nonmelanoma skin cancers 50 Mass spectrometry 50 hematological diseases 50 spectroscopic technique 50 multifactorial disease 50 EGFR blockers 50 autologous transplantation 50 Her2 positive 50 prostate cancer PCa 50 vascular insufficiency 50 bowel capsule endoscopy 50 circulating endothelial cells 50 BCIRG 50 pharmacologic therapy 50 AML acute myeloid 50 microarray gene expression 50 invasive ductal 50 Sanger Sequencing 50 perfusion imaging 50 p# biomarkers 50 adverse cytogenetics 50 T1a 50 intravenous dosing 50 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 50 Sanger sequencing 50 histological diagnosis 50 radiosensitive 50 prognostic biomarkers 50 squamous histology 50 molecular imprinting 50 noninvasive technique 50 colonoscopic 50 benign uterine 50 squamous 50 microarray datasets 50 angiogenesis inhibition 50 proteasome inhibitor 50 molecular subtypes 50 intraoperative radiotherapy 50 skin sparing mastectomy 50 Alessandro Riva 50 Minimally invasive surgery 50 Ductal carcinoma 50 FDG PET scans 50 mutated KRAS gene 50 empiric therapy 50 TTF therapy 50 ConclusionThis 50 clinicopathological 50 lung adenocarcinoma 50 HER2 expression 50 ROCHESTER Minn. Mayo Clinic 50 abnormal cytology 50 cranial irradiation 50 underwent prostate biopsy 50 bladder carcinoma 50 lung resection 50 Electronic Brachytherapy 50 needle biopsies 50 anthracycline containing 50 ER CHOP 50 erlotinib Tarceva 50 NOD mouse 50 Laparoscopic surgery 50 ADME properties 50 hereditary deficiency 50 alveolar rhabdomyosarcoma 50 recurrent bladder 50 bispecific antibody 50 enlarged prostate glands 49 Leukemias 49 endometrial biopsy 49 Canvaxin 49 stage IIIb IV 49 Adjuvant therapy 49 CT angiography CTA 49 vaccine Oncophage 49 fallopian tube carcinoma 49 chemopreventive agents 49 genomewide association studies 49 advanced adenomas 49 mammographically 49 thermogram 49 isotype 49 transfemoral approach 49 Deforolimus 49 esophagogastric junction 49 therapeutical 49 Acute myeloid leukemia 49 bone marrow biopsies 49 precursor lesions 49 curative therapies 49 VerifyNow 49 biochemical assays 49 Photodynamic therapy 49 SPECT imaging 49 glioblastoma tumors 49 leiomyomas 49 boron neutron capture 49 gemcitabine carboplatin 49 thiopurine 49 opioid antagonists 49 pretest probability 49 bioengineered tissue 49 perfusion MRI 49 randomized discontinuation 49 peptidic 49 Mathematical modeling 49 non nucleoside 49 oligonucleotide microarrays 49 enzyme metabolizes 49 antirheumatic 49 electrospray mass spectrometry 49 cervical lymph nodes 49 standard chemotherapy regimens 49 ophthalmology dermatology cardiovascular disease 49 therapy IMRT 49 AGHD 49 gynecologic procedures 49 ablative therapies 49 K ras mutations 49 hamartomas 49 BSGI MBI 49 RF ablation 49 electroactive 49 tomotherapy 49 histological subtypes 49 antiangiogenesis 49 FDG PET CT 49 Saladax 49 standard chemotherapy regimen 49 aromatase inhibitor therapy 49 Bayesian statistical 49 Pertuzumab 49 viral tropism 49 adjuvant radiotherapy 49 DCVax 49 chromosomal anomalies 49 radiation chemoradiation 49 locoregional 49 detecting coronary artery 49 generalisable 49 empiric treatment 49 monophasic 49 CanAg 49 biological macromolecules 49 PEGylated interferon 49 HPV genotyping 49 lung nodule 49 CFTR gene mutations 49 Waldenstrom macroglobulinemia 49 peritoneal cancer 49 preclinical efficacy 49 cerebral angiography 49 polypoid 49 BRCA1 BRCA2 49 Dr. Vitetta 49 Lodamin 49 Balloon Sinuplasty 49 Polycythemia vera 49 GBA mutations 49 thymectomy 49 endospores 49 Circulating tumor cells 49 acyclovir Lauriad ® 49 molecular mimicry 49 MTT assay 49 inhaled bronchodilators 49 midstage studies 49 ductal carcinomas 49 CYP#D# gene 49 benign thyroid nodules 49 multivariate statistical 49 environmental toxicants 49 GliaSite 49 Dr. Kountakis 49 cellular immunotherapy 49 evaluating Nexavar 49 FLT PET 49 2DG 49 targets EpCAM expressing 49 RNA amplification 49 liver metastases 49 culturing 49 oncologic 49 advanced medullary thyroid 49 samalizumab 49 anticancer therapeutics 49 shotgun sequencing 49 pelvic malignancies 49 PCNSL 49 arteriography 49 thermal ablation 49 Inhaled nitric oxide 49 Mohs surgery 49 RECIST Response Evaluation Criteria 49 transabdominal 49 serum biomarkers 49 cytogenic 49 GRNCM1 49 upper gastrointestinal endoscopy 49 AMN# [001] 49 massively parallel sequencing 49 humanized mice 49 extracapsular extension 49 TILLING 49 bronchoscopic procedures 49 fibrate drugs 49 human microdosing 49 Gleevec imatinib 49 etiologic agent 49 CTLA4 Ig 49 Vaxfectin TM 49 Gleevac 49 ADVEXIN therapy 49 warfarin dosing 49 RGD peptides 49 FOLFIRI alone 49 colon resection 49 Xenopus embryos 49 TMPRSS2 ERG 49 TTF Therapy 49 human ESCs 49 endoluminal 49 anagrelide 49 thymic carcinoma 49 FTIs 49 Dabigatran 49 Glioblastomas 49 malignant lymphoma 49 carotid stents 49 recombinant enzyme 49 Aspergillus nidulans 49 granulosa cell 49 shrink cancerous tumors 49 gastrointestinal malignancies 49 BLP# 49 taxotere 49 PI3K inhibitors 49 urothelial carcinoma 49 convenient dosing regimens 49 metastatic renal 49 vitamin D analogs 49 Topical treatments 49 inferential statistics 49 Acoustic tweezers 49 detect XMRV 49 telomere biology 49 intestinal biopsy 49 transurethral resection 49 T1c 49 induced pluripotent cells 49 bone scintigraphy 49 pretreatments 49 osteoporotic compression fractures 49 antireflux surgery 49 colorectal neoplasms 49 chemosensitivity 49 hypervascular tumors 49 automated microscopy 49 curable cancers 49 dimensional conformal radiotherapy 49 axillary dissection 49 histocompatibility 49 myoblast 49 extrapleural pneumonectomy 49 ductal lavage 49 aromatase inhibitors AIs 49 Estrogen Receptor 49 chemotherapy docetaxel 49 PET CT scans 49 kinase inhibition 49 RT PCR assay 48 radioiodine therapy 48 epiretinal 48 curability 48 nematicides 48 BRCA mutation carriers 48 NeuroFlo 48 haematopoietic 48 breast cancer subtypes 48 synDNA TM 48 distinct subtypes 48 von Willebrand 48 Fc gamma receptor 48 Tectin TM 48 Novartis AG Gleevec 48 Skeletal muscle 48 prognostic indicator 48 Squamous cell 48 Affinitak 48 nephrectomies 48 electrochemical sensors 48 topical calcineurin inhibitors 48 trabectedin 48 metastatic RCC 48 HepaMate ™ 48 endometrial cancers 48 Haptoglobin 48 inhaled tobramycin 48 myoblast therapy 48 pre malignant lesions 48 Personalised medicine 48 primary immunodeficiencies 48 psoriasis Crohn disease 48 antiepileptics 48 lymph node removal 48 Peregrine bavituximab 48 Chronic lymphocytic leukemia CLL 48 Group RTOG 48 CaPSURE 48 Shark cartilage 48 Avastin adjuvant 48 bronchoscopies 48 pancreatic cysts 48 prospectively enrolled 48 partial nephrectomy 48 oncogenic mutations 48 unspecialized 48 comparative genomic 48 prostate cancer CRPC 48 sodium stibogluconate 48 intraperitoneal chemotherapy 48 precancer 48 Mechanical ventilation 48 Szeinbach 48 noninvasive ultrasound 48 Phase IIIb study 48 paclitaxel Taxol R 48 median survivals 48 reversible contraceptive 48 fluorescent pigments 48 clinico pathological 48 treating peripheral arterial 48 gastro intestinal stromal tumors 48 debulking surgery 48 desorption electrospray ionization 48 multivariate analyzes 48 lymph node dissection 48 AF ablation procedures 48 novel peptide 48 islet isolation 48 Avastin Tarceva 48 neurosensory 48 telomere lengths 48 HCV protease inhibitors 48 stent coating 48 colorectal cancer CRC 48 Lumbar Interbody Fusion 48 Deinococcus 48 vestibular schwannomas 48 #F FDG 48 ovarian malignancy 48 Gefitinib 48 EUS FNA 48 microscopic colitis 48 infective endocarditis 48 cytoreductive surgery 48 hESC derived RPE cells 48 antimicrobial prophylaxis 48 PCR Polymerase Chain Reaction 48 oral clodronate 48 malignant polyps 48 melanoma lesions 48 PARP inhibition 48 squamous cell histology 48 chronic osteomyelitis 48 retrospective observational 48 nodular melanoma 48 Bayer HealthCare Onyx Pharmaceuticals 48 osteoarthritic pain 48 inexpensively formulate 48 Coronary artery bypass graft 48 developmental neurotoxicity 48 situ hybridisation 48 CSF biomarkers 48 lymphoid malignancies 48 limb sparing 48 multivessel disease 48 GRN# 48 Cardiolite ® 48 newer atypical antipsychotics 48 Arranon 48 immune suppressing 48 Velcade bortezomib 48 prenatal diagnostic 48 relapsed ovarian cancer 48 ClearPath HDR 48 Removab 48 transcatheter closure 48 beta1 integrin 48 predictive biomarkers 48 Mesenchymal 48 acute myeloid 48 Erimos 48 hyperinsulinemic euglycemic clamp 48 stereotactic body 48 inexpensively formulate hydrogen 48 epitope mapping 48 EBUS FNA 48 EGS# 48 retrospective cohort 48 genetic makeups 48 prospectively stratified 48 LLLT 48 scanning tunneling microscopy STM 48 Certolizumab pegol 48 presymptomatic 48 benign prostatic hypertrophy BPH 48 intravascular catheters 48 renal cysts 48 immunosuppressives 48 BRAF inhibitor 48 hepatic metastases 48 thrombo embolic 48 immunosuppressive therapies 48 chromosome translocations 48 precancerous cervical 48 preoperative chemotherapy 48 recombinant antibodies 48 LTRAs 48 pancreatic NET 48 endoscopic examinations 48 Oncimmune 48 iniparib BSI 48 microRNA expression 48 oral Hycamtin 48 System IPSS 48 filamentous fungi 48 DEEP AF 48 ErbB2 positive 48 oligodendrogliomas 48 squamous carcinoma 48 riociguat 48 phase IIIb 48 anticholinergic agents 48 hematopoietic progenitor cells 48 laparoscopic colon 48 MERCI Retriever 48 Francisella 48 gonococcal 48 Cristofanilli 48 quantitative PCR qPCR 48 fine needle aspiration 48 paclitaxel poliglumex 48 abdominal subcutaneous fat 48 transcervical 48 Alequel ™ 48 BanLec 48 cisplatin chemotherapy 48 laser desorption 48 vesicoureteral reflux VUR 48 familial pancreatic cancer 48 translational genomics 48 perioperative morbidity 48 Carotid artery stenting 48 VADT 48 ReN# 48 Dasatinib 48 molecules peptides 48 BR.# 48 eIF 4E 48 antiplatelet medications 48 metastatic lung cancer 48 Notch inhibitor 48 human secretin 48 sonographic diagnosis 48 malignant lesion 48 adenoviral conjunctivitis 48 neratinib 48 pancreatic cyst 48 endovenous laser ablation 48 direct laryngoscopy 47 undergoing coronary angiography 47 precancerous condition 47 retaspimycin 47 visceral metastases 47 M. paratuberculosis 47 LC#m# 47 Artsimovitch 47 LDL apheresis 47 hematological malignancy 47 nonproliferative 47 embryo clones 47 care regimens CCR 47 hematologists oncologists 47 solubilizing 47 xenograft mouse 47 noninflammatory 47 metastatic lesions 47 antisense therapies 47 viral vectors 47 K ras gene 47 transoral 47 Gleevec imatinib mesylate 47 nasal CPAP 47 afamelanotide